ReP USP - Resultado da busca

Artigo de periodico
Rethinking treatment paradigms: neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer (2024)
Bouassaly, Jenna; Karimi, Naser; Kowalski, Luiz Paulo ; Sultanem, Khalil; Alaoui-Jamali, Moulay; Mlynarek, Alex; Mascarella, Marco; Hier, Michael; Sadeghi, Nader; Silva, Sabrina Daniela da
Source: Critical revies in oncology hematology. Unidade: FM
Subjects: CO-TERAPIA, HPV, NEOPLASIAS DE CABEÇA E PESCOÇO, RADIOTERAPIA, TERAPIA COMBINADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOUASSALY, Jenna et al. Rethinking treatment paradigms: neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer. Critical revies in oncology hematology, v. 196, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76773. Acesso em: 18 maio 2025.
APA
Bouassaly, J., Karimi, N., Kowalski, L. P., Sultanem, K., Alaoui-Jamali, M., Mlynarek, A., et al. (2024). Rethinking treatment paradigms: neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer. Critical revies in oncology hematology, 196. doi:10.1016/j.critrevonc.2024.104326
NLM
Bouassaly J, Karimi N, Kowalski LP, Sultanem K, Alaoui-Jamali M, Mlynarek A, Mascarella M, Hier M, Sadeghi N, Silva SD da. Rethinking treatment paradigms: neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer [Internet]. Critical revies in oncology hematology. 2024 ; 196[citado 2025 maio 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76773
Vancouver
Bouassaly J, Karimi N, Kowalski LP, Sultanem K, Alaoui-Jamali M, Mlynarek A, Mascarella M, Hier M, Sadeghi N, Silva SD da. Rethinking treatment paradigms: neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer [Internet]. Critical revies in oncology hematology. 2024 ; 196[citado 2025 maio 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76773
Artigo de periodico
Stress induced phosphoprotein 1 overexpression controls proliferation, migration and invasion and is associated with poor survival in oral squamous cell carcinoma (2023)
Dourado, Mauricio Rocha ; Elseragy, Amr; Costa, Bruno Cesar da; Téo, Fábio Haach; Guimarães, Gustavo Narvaes; Machado, Renato Assis ; Risteli, Maija; Wahbi, Wafa; Rocha, Clarissa Araújo Gurgel; Paranaíba, Lívia Máris Ribeiro ; González-Arriagada, Wilfredo Alejandro ; Silva, Sabrina Daniela da; Rangel, Ana Lúcia Carrinho Ayroza ; Marques, Marcelo Rocha; Rossa Junior, Carlos ; Salo, Tuula; Coletta, Ricardo D.
Unidade: HRAC
Subjects: NEOPLASIAS BUCAIS, CARCINOMA DE CÉLULAS ESCAMOSAS, PROGNÓSTICO, PROLIFERAÇÃO CELULAR, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOURADO, Mauricio Rocha et al. Stress induced phosphoprotein 1 overexpression controls proliferation, migration and invasion and is associated with poor survival in oral squamous cell carcinoma. v. 12, n. 1, 2023Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.1085917. Acesso em: 18 maio 2025.
APA
Dourado, M. R., Elseragy, A., Costa, B. C. da, Téo, F. H., Guimarães, G. N., Machado, R. A., et al. (2023). Stress induced phosphoprotein 1 overexpression controls proliferation, migration and invasion and is associated with poor survival in oral squamous cell carcinoma, 12( 1). doi:10.3389/fonc.2022.1085917
NLM
Dourado MR, Elseragy A, Costa BC da, Téo FH, Guimarães GN, Machado RA, Risteli M, Wahbi W, Rocha CAG, Paranaíba LMR, González-Arriagada WA, Silva SD da, Rangel ALCA, Marques MR, Rossa Junior C, Salo T, Coletta RD. Stress induced phosphoprotein 1 overexpression controls proliferation, migration and invasion and is associated with poor survival in oral squamous cell carcinoma [Internet]. 2023 ; 12( 1):[citado 2025 maio 18 ] Available from: https://doi.org/10.3389/fonc.2022.1085917
Vancouver
Dourado MR, Elseragy A, Costa BC da, Téo FH, Guimarães GN, Machado RA, Risteli M, Wahbi W, Rocha CAG, Paranaíba LMR, González-Arriagada WA, Silva SD da, Rangel ALCA, Marques MR, Rossa Junior C, Salo T, Coletta RD. Stress induced phosphoprotein 1 overexpression controls proliferation, migration and invasion and is associated with poor survival in oral squamous cell carcinoma [Internet]. 2023 ; 12( 1):[citado 2025 maio 18 ] Available from: https://doi.org/10.3389/fonc.2022.1085917
Artigo de periodico
Trophoblast cell surface antigen 2 expression predicts outcome in oral squamous cell carcinomas (2022)
Dourado, Mauricio Rocha ; Machado, Renato Assis ; Paranaíba, Lívia Máris Ribeiro ; González-Arriagada, Wilfredo Alejandro ; Silva, Sabrina Daniela da; Sawazaki-Calone, Íris; Graner, Edgard ; Salo, Tuula; Coletta, Ricardo D.
Source: Oral Diseases. Unidade: HRAC
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, SOBREVIDA, TROFOBLASTO, ANTÍGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOURADO, Mauricio Rocha et al. Trophoblast cell surface antigen 2 expression predicts outcome in oral squamous cell carcinomas. Oral Diseases, v. 28, n. 4, p. 1085-1093, 2022Tradução . . Disponível em: https://doi.org/10.1111/odi.13809. Acesso em: 18 maio 2025.
APA
Dourado, M. R., Machado, R. A., Paranaíba, L. M. R., González-Arriagada, W. A., Silva, S. D. da, Sawazaki-Calone, Í., et al. (2022). Trophoblast cell surface antigen 2 expression predicts outcome in oral squamous cell carcinomas. Oral Diseases, 28( 4), 1085-1093. doi:10.1111/odi.13809
NLM
Dourado MR, Machado RA, Paranaíba LMR, González-Arriagada WA, Silva SD da, Sawazaki-Calone Í, Graner E, Salo T, Coletta RD. Trophoblast cell surface antigen 2 expression predicts outcome in oral squamous cell carcinomas [Internet]. Oral Diseases. 2022 ; 28( 4): 1085-1093.[citado 2025 maio 18 ] Available from: https://doi.org/10.1111/odi.13809
Vancouver
Dourado MR, Machado RA, Paranaíba LMR, González-Arriagada WA, Silva SD da, Sawazaki-Calone Í, Graner E, Salo T, Coletta RD. Trophoblast cell surface antigen 2 expression predicts outcome in oral squamous cell carcinomas [Internet]. Oral Diseases. 2022 ; 28( 4): 1085-1093.[citado 2025 maio 18 ] Available from: https://doi.org/10.1111/odi.13809
Artigo de periodico
Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer (2018)
Carnielli, Carolina Moretto; Macedo, Carolina Carneiro Soares; Rossi, Tatiane de; Granato, Daniela Campos; Rivera, César; Domingues, Romênia Ramos; Pauletti, Bianca Alves; Yokoo, Sami; Heberle, Henry; Busso-Lopes, Ariane Fidelis; Cervigne, Nilva Karla; Sawazaki-Caloni, Iris; Meirelles, Gabriela Vaz; Marchi, Fabio Albuquerque; Telles, Guilherme Pimentel; Minghim, Rosane ; Ribeiro, Ana Carolina Prado; Brandão, Thaís Bianca; Castro Jr, Gilberto de; González-Arriagada, Wilfredo Alejandro; Gomes, Alexandre; Penteado, Fabio; Santos-Silva, Alan Roger; Lopes, Márcio Ajudarte; Rodrigues, Priscila Campioni; Sundquist, Elias; Salo, Tuula; Silva, Sabrina Daniela da; Alaoui-Jamali, Moulay A; Graner, Edgard; Fox, Jay W; Coletta, Ricardo Della; Leme, Adriana Franco Paes
Source: Nature Communications. Unidade: ICMC
Subjects: NEOPLASIAS BUCAIS, PROTEÔMICA, APRENDIZADO COMPUTACIONAL, DIAGNÓSTICO POR COMPUTADOR, TECNOLOGIAS DA SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARNIELLI, Carolina Moretto et al. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nature Communications, v. 9, p. 1-17, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41467-018-05696-2. Acesso em: 18 maio 2025.
APA
Carnielli, C. M., Macedo, C. C. S., Rossi, T. de, Granato, D. C., Rivera, C., Domingues, R. R., et al. (2018). Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nature Communications, 9, 1-17. doi:10.1038/s41467-018-05696-2
NLM
Carnielli CM, Macedo CCS, Rossi T de, Granato DC, Rivera C, Domingues RR, Pauletti BA, Yokoo S, Heberle H, Busso-Lopes AF, Cervigne NK, Sawazaki-Caloni I, Meirelles GV, Marchi FA, Telles GP, Minghim R, Ribeiro ACP, Brandão TB, Castro Jr G de, González-Arriagada WA, Gomes A, Penteado F, Santos-Silva AR, Lopes MA, Rodrigues PC, Sundquist E, Salo T, Silva SD da, Alaoui-Jamali MA, Graner E, Fox JW, Coletta RD, Leme AFP. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer [Internet]. Nature Communications. 2018 ; 9 1-17.[citado 2025 maio 18 ] Available from: https://doi.org/10.1038/s41467-018-05696-2
Vancouver
Carnielli CM, Macedo CCS, Rossi T de, Granato DC, Rivera C, Domingues RR, Pauletti BA, Yokoo S, Heberle H, Busso-Lopes AF, Cervigne NK, Sawazaki-Caloni I, Meirelles GV, Marchi FA, Telles GP, Minghim R, Ribeiro ACP, Brandão TB, Castro Jr G de, González-Arriagada WA, Gomes A, Penteado F, Santos-Silva AR, Lopes MA, Rodrigues PC, Sundquist E, Salo T, Silva SD da, Alaoui-Jamali MA, Graner E, Fox JW, Coletta RD, Leme AFP. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer [Internet]. Nature Communications. 2018 ; 9 1-17.[citado 2025 maio 18 ] Available from: https://doi.org/10.1038/s41467-018-05696-2
Artigo de periodico
Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer (2016)
Elias, Eliana Vanina; Castro, Nadia Pereira de; Pineda, Paulo Henrique Baldan; Abuázar, Carolina Sens; Osório, Cynthia Aparecida Bueno de Toledo; Pinilla, Mabel Gigliola; Silva, Sabrina Daniela da; Camargo, Anamaria Aranha; Silva Júnior, Wilson Araújo da; Ferreira, Elisa Napolitano e; Brentani, Helena Paula; Carraro, Dirce Maria
Source: Oncotarget. Unidades: FMRP, FM
Subjects: NEOPLASIAS MAMÁRIAS, CARCINOMA DE DUCTOS INFILTRANTE, MARCADOR MOLECULAR, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELIAS, Eliana Vanina et al. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer. Oncotarget, v. 7, n. 46, p. 75672-75684, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.12352. Acesso em: 18 maio 2025.
APA
Elias, E. V., Castro, N. P. de, Pineda, P. H. B., Abuázar, C. S., Osório, C. A. B. de T., Pinilla, M. G., et al. (2016). Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer. Oncotarget, 7( 46), 75672-75684. doi:10.18632/oncotarget.12352
NLM
Elias EV, Castro NP de, Pineda PHB, Abuázar CS, Osório CAB de T, Pinilla MG, Silva SD da, Camargo AA, Silva Júnior WA da, Ferreira EN e, Brentani HP, Carraro DM. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer [Internet]. Oncotarget. 2016 ; 7( 46): 75672-75684.[citado 2025 maio 18 ] Available from: https://doi.org/10.18632/oncotarget.12352
Vancouver
Elias EV, Castro NP de, Pineda PHB, Abuázar CS, Osório CAB de T, Pinilla MG, Silva SD da, Camargo AA, Silva Júnior WA da, Ferreira EN e, Brentani HP, Carraro DM. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer [Internet]. Oncotarget. 2016 ; 7( 46): 75672-75684.[citado 2025 maio 18 ] Available from: https://doi.org/10.18632/oncotarget.12352
Artigo de periodico
TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target (2014)
Silva, Sabrina Daniela da; Alaoui-Jamali , Moulay A.; Soares, Fernando Augusto; Carraro, Dirce Maria; Brentani, Helena Paula; Hier, Michael; Rogatto, Silvia Regina; Kowalski, Luiz Paulo
Source: Cancer. Unidade: FO
Subjects: METÁSTASE NEOPLÁSICA, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Sabrina Daniela da et al. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer, v. 120, n. 3, p. 352-362, 2014Tradução . . Disponível em: https://doi.org/10.1002/cncr.28404. Acesso em: 18 maio 2025.
APA
Silva, S. D. da, Alaoui-Jamali , M. A., Soares, F. A., Carraro, D. M., Brentani, H. P., Hier, M., et al. (2014). TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer, 120( 3), 352-362. doi:10.1002/cncr.28404
NLM
Silva SD da, Alaoui-Jamali MA, Soares FA, Carraro DM, Brentani HP, Hier M, Rogatto SR, Kowalski LP. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target [Internet]. Cancer. 2014 ; 120( 3): 352-362.[citado 2025 maio 18 ] Available from: https://doi.org/10.1002/cncr.28404
Vancouver
Silva SD da, Alaoui-Jamali MA, Soares FA, Carraro DM, Brentani HP, Hier M, Rogatto SR, Kowalski LP. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target [Internet]. Cancer. 2014 ; 120( 3): 352-362.[citado 2025 maio 18 ] Available from: https://doi.org/10.1002/cncr.28404
Artigo de periodico
HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis (2012)
Bitu, Carolina Cavalcante; Destro, Maria Fernanda de Souza Setúbal; Carrera, Manoela; Silva, Sabrina Daniela da; Graner, Edgard; Kowalski, Luiz Paulo; Soares, Fernando Augusto; Coletta, Ricardo D
Source: BMC Cancer. Unidade: FO
Subjects: NEOPLASIAS, PROLIFERAÇÃO CELULAR, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITU, Carolina Cavalcante et al. HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis. BMC Cancer, 2012Tradução . . Disponível em: https://doi.org/10.1186/1471-2407-12-146. Acesso em: 18 maio 2025.
APA
Bitu, C. C., Destro, M. F. de S. S., Carrera, M., Silva, S. D. da, Graner, E., Kowalski, L. P., et al. (2012). HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis. BMC Cancer. doi:10.1186/1471-2407-12-146
NLM
Bitu CC, Destro MF de SS, Carrera M, Silva SD da, Graner E, Kowalski LP, Soares FA, Coletta RD. HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis [Internet]. BMC Cancer. 2012 ;[citado 2025 maio 18 ] Available from: https://doi.org/10.1186/1471-2407-12-146
Vancouver
Bitu CC, Destro MF de SS, Carrera M, Silva SD da, Graner E, Kowalski LP, Soares FA, Coletta RD. HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis [Internet]. BMC Cancer. 2012 ;[citado 2025 maio 18 ] Available from: https://doi.org/10.1186/1471-2407-12-146
Artigo de periodico
Epigenetic silencing of CRABP2 and MX1 in head and neck tumors (2009)
Calmon, Marilia de Freitas; Rodrigues, Rodrigo Vieira; Kaneto, Carla Martins; Moura, Ricardo Pereira de; Silva, Sabrina Daniela da; Mota, Louise Danielle C; Pinheiro, Daniel Guariz; Torres, Cesar; Carvalho, Alex Franco de; Cury, Patricia Maluf; Nunes, Fábio Daumas; Nishimoto, Ines Nobuko; Soares, Fernando Augusto; Silva, Adriana M. A; Kowalski, Luis Paulo; Brentani, Helena; Zanelli, Cleslei Fernando; Silva Júnior, Wilson Araújo da; Rahal, Paula; Tajara, Eloiza Helena; Carraro, Dirce Maria; Camargo, Anamaria Aranha; Valentini, Sandro Roberto
Source: Neoplasia. Unidades: FO, FMRP
Subjects: GENES, CARCINOMA, MUCOSA ORAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALMON, Marilia de Freitas et al. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia, v. 11, n. 12, p. 1329-1339, 2009Tradução . . Acesso em: 18 maio 2025.
APA
Calmon, M. de F., Rodrigues, R. V., Kaneto, C. M., Moura, R. P. de, Silva, S. D. da, Mota, L. D. C., et al. (2009). Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia, 11( 12), 1329-1339.
NLM
Calmon M de F, Rodrigues RV, Kaneto CM, Moura RP de, Silva SD da, Mota LDC, Pinheiro DG, Torres C, Carvalho AF de, Cury PM, Nunes FD, Nishimoto IN, Soares FA, Silva AMA, Kowalski LP, Brentani H, Zanelli CF, Silva Júnior WA da, Rahal P, Tajara EH, Carraro DM, Camargo AA, Valentini SR. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia. 2009 ; 11( 12): 1329-1339.[citado 2025 maio 18 ]
Vancouver
Calmon M de F, Rodrigues RV, Kaneto CM, Moura RP de, Silva SD da, Mota LDC, Pinheiro DG, Torres C, Carvalho AF de, Cury PM, Nunes FD, Nishimoto IN, Soares FA, Silva AMA, Kowalski LP, Brentani H, Zanelli CF, Silva Júnior WA da, Rahal P, Tajara EH, Carraro DM, Camargo AA, Valentini SR. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia. 2009 ; 11( 12): 1329-1339.[citado 2025 maio 18 ]
Artigo de periodico
CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients (2009)
Olivieri, Eloisa Helena Ribeiro; Silva, Sabrina Daniela da; Mendonça, Fernando Fernandes; Urata, Yuri Nagamine; Vidal, Daniel Onofre; Faria, Marcília de Araújo Medrado; Nishimoto, Inês Nobuko; Rainho, Claudia Aparecida; Kowalski, Luiz Paulo; Rogatto, Silvia Regina
Source: Oral Oncology. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, FATORES DE RISCO, NEOPLASIAS DE CABEÇA E PESCOÇO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVIERI, Eloisa Helena Ribeiro et al. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral Oncology, v. 45, n. 9, p. I, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2009.03.004. Acesso em: 18 maio 2025.
APA
Olivieri, E. H. R., Silva, S. D. da, Mendonça, F. F., Urata, Y. N., Vidal, D. O., Faria, M. de A. M., et al. (2009). CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral Oncology, 45( 9), I. doi:10.1016/j.oraloncology.2009.03.004
NLM
Olivieri EHR, Silva SD da, Mendonça FF, Urata YN, Vidal DO, Faria M de AM, Nishimoto IN, Rainho CA, Kowalski LP, Rogatto SR. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients [Internet]. Oral Oncology. 2009 ; 45( 9): I.[citado 2025 maio 18 ] Available from: https://doi.org/10.1016/j.oraloncology.2009.03.004
Vancouver
Olivieri EHR, Silva SD da, Mendonça FF, Urata YN, Vidal DO, Faria M de AM, Nishimoto IN, Rainho CA, Kowalski LP, Rogatto SR. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients [Internet]. Oral Oncology. 2009 ; 45( 9): I.[citado 2025 maio 18 ] Available from: https://doi.org/10.1016/j.oraloncology.2009.03.004

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration